Shahrokh Shariat

From Wikipedia, the free encyclopedia
Shahrokh Shariat
Born (1973-09-20) September 20, 1973 (age 49)
EducationUniversity of Vienna
Baylor College of Medicine
University of Texas Southwestern Medical Center
Memorial Sloan-Kettering Cancer Center
Alma materUniversity of Vienna
Baylor College of Medicine
University of Texas Southwestern Medical Center
Memorial Sloan-Kettering Cancer Center
Occupation(s)Physician, Surgeon, Oncologist, Urologist

Shahrokh François Shariat (born September 20, 1973) is currently professor and chairman of the Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria. He is also adjunct professor of urology at Weill Cornell Medical Center, New York, NY; adjunct professor of urology at the University of Texas Southwestern Medical Center, Dallas, TX, USA; adjunct professor of urology at the Faculty of Medicine, Charles University, Prague, CZ; adjunct professor of urology at I.M. Sechenov First Moscow State Medical University, Moscow, RU; honorary professor of urology, University of Jordan, Amman, JO; doctor honoris causa, Carol Davila University of Medicine and Pharmacy,[1] Bucharest, RO; and doctor honoris causa, Semmelweis University, Budapest, Hungary. He has published more than 1500 peer-reviewed research papers, more than 600 non-peer-reviewed papers, and 26 book chapters. Shahrokh Shariat specializes in treating urologic malignancies. He has been voted as the most influential urologist in 2020[2] and also the most cited prostate cancer researcher[3] in the German speaking area.

Awards and memberships[edit]

Shahrokh Shariat is the recipient of various national and international awards. He has, for example, received the prestigious Crystal Matula Award[4] from the European Urological Association and the Gold Cystoscope 2017[5] from the American Urological Association. He is a member of 25 academic societies and editorial board of 26 scientific journals. In addition, he is an editorial board member of European Urology, BJU International, World Journal of Urology, Current Opinion in Urology (editor in chief), and Immunotherapy among others. Dr. Shariat also reviews grant proposals for cancer research foundations and paper submissions for many journals, heads a medical charity for refugees and is on the medical advisory board for two other charities. He joined in 2010 the New York Presbyterian Hospital and Weill Cornell Medical Center in New York, NY.

Research and areas of focus[edit]

As a specialist for treating urological cancers[6][7][8] Shahrokh Shariat is the holder of four patents stemming from his research into prostate cancer and bladder cancer. Furthermore, he is currently spearheading several collaborative multicenter groups (Bladder Cancer Research Consortium, The Bladder Cancer Detection Group, and The Upper Tract Urothelial Carcinoma Collaboration) and prospective clinical trials.

Dr. Shariat's research focuses on the following areas:

  1. Translational research in robotic prostatectomy and prostate cancer
  2. Translational research in bladder cancer and upper tract urothelial carcinoma
  3. Gene, vaccine and immuno therapies for urologic diseases with focus on bladder and prostate cancers
  4. Minimal invasive instrumental treatment modalities for BPH and prostate cancer.


  1. ^ "Shahrokh Shariat awarded honorary doctorate by Carol Davila University of Medicine and Pharmacy". Retrieved 5 July 2022.
  2. ^ "Big-Data-Analyse von SCI-Papieren, die 2020 in der Urologie veröffentlicht wurden". Retrieved 5 July 2022.
  3. ^ "Alle gegen Prostatakrebs Publikationsanalyse 2010-2019: Urologische Forschung von Mario Rembold, Laborjournal 1-2/2021". Laborjournal. Retrieved 5 July 2022.
  4. ^ "Pavone-Macaluso wins EAU Willy Gregoir Award". EAU. Retrieved 5 July 2022.
  5. ^ "Gold Cystoscope Award". American Urological Association. Retrieved 5 July 2022.
  6. ^ Reiter-Reitbauer, Magdalena. "Über Blasenkrebs sprechen – aber richtig". Retrieved 5 July 2022.
  7. ^ Kruckenhauser, Pia. "Spermageddon: Können die Männer bald keine Kinder mehr zeugen?". DerStandard. Retrieved 5 July 2022.
  8. ^ "STOP Blasenkrebs Mai ist der internationale Blasenkrebsmonat!". Kronen Zeitung. Retrieved 5 July 2022.

External links[edit]